121 related articles for article (PubMed ID: 38605204)
1. Outcomes of SDHB pathogenic variant carriers: A systematic review and meta-analysis.
Davidoff DF; De Abreu Lourenco R; Tsang VHM; Benn DE; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38605204
[TBL] [Abstract][Full Text] [Related]
2. Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter Study.
Davidoff DF; Benn DE; Field M; Crook A; Robinson BG; Tucker K; De Abreu Lourenco R; Burgess JR; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1907-e1916. PubMed ID: 35037935
[TBL] [Abstract][Full Text] [Related]
3. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
[TBL] [Abstract][Full Text] [Related]
4. Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers.
White G; Velusamy A; Anandappa S; Masucci M; Breen LA; Joshi M; McGowan B; Hubbard JGH; Obholzer R; Christodoulou D; Jacques A; Touska P; Hassan FU; Izatt L; Carroll PV
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35060925
[TBL] [Abstract][Full Text] [Related]
5. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
[TBL] [Abstract][Full Text] [Related]
6. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
[TBL] [Abstract][Full Text] [Related]
7. Risk of metastatic pheochromocytoma and paraganglioma in
Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
[TBL] [Abstract][Full Text] [Related]
8. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
Bancel LP; Masso V; Dessein AF; Aubert S; Leteurtre E; Coppin L; Odou MF; Cao CD; Cardot-Bauters C; Pigny P
J Clin Endocrinol Metab; 2023 Aug; 108(9):2343-2352. PubMed ID: 36848172
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
11. The phenotype of
Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
[TBL] [Abstract][Full Text] [Related]
12. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
13.
Bayley JP; Bausch B; Jansen JC; Hensen EF; van der Tuin K; Corssmit EP; Devilee P; Neumann HP
J Med Genet; 2023 Jan; 60(1):25-32. PubMed ID: 34750193
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
Chen H; Yao W; He Q; Yu X; Bian B
BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
[TBL] [Abstract][Full Text] [Related]
18. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
[TBL] [Abstract][Full Text] [Related]
19. Succinate Dehydrogenase Complex Iron Sulfur Subunit B (SDHB) Immunohistochemistry in Pheochromocytoma, Head and Neck Paraganglioma, Thoraco-Abdomino-Pelvic Paragangliomas: Is It a Good Idea to Use in Routine Work?
Gul AE; Keser SH; Barisik NO; Gurbuz YS; Sensu S; Erdogan N
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1721-1729. PubMed ID: 34181326
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis.
van Hulsteijn LT; Dekkers OM; Hes FJ; Smit JW; Corssmit EP
J Med Genet; 2012 Dec; 49(12):768-76. PubMed ID: 23099648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
